Skip to content

Database for Interstitial Lung Disease

Clinical Database for the Early Recognition of Pulmonary Parenchymal Involvement in Patients With Systemic Diseases Bearing a Risk for Interstitial Lung Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04707781
Enrollment
412
Registered
2021-01-13
Start date
2021-05-01
Completion date
2029-01-31
Last updated
2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Diseases, Interstitial

Brief summary

The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.

Interventions

DIAGNOSTIC_TESTchest CT

assessment of interstitial lung disease using chest CT

Sponsors

Medical University of Graz
Lead SponsorOTHER
Boehringer Ingelheim
CollaboratorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age: ≥ 18 years * patients with a known systemic disease bearing a risk for ILD * signed informed consent (for prospective part)

Exclusion criteria

* Age \< 18 years * comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)

Design outcomes

Primary

MeasureTime frameDescription
DLCO%pred (carbon monoxide diffusing capacity) at time of ILD diagnosis5 yearsThe investigators aim to assess DLCO% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the DLCO%pred at time of ILD diagnosis

Secondary

MeasureTime frameDescription
FVC%pred (Forced vital capacity) at time of ILD diagnosis5 yearsThe investigators aim to assess FVC% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the FVC%pred at time of ILD diagnosis

Countries

Austria

Contacts

Primary ContactGabor Kovacs, MD
gabor.kovacs@klinikum-graz.at+43-316-385

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026